Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > 6-(2-Chloro-4-thiazol-5-yl-phenyl)-8-ethyl-2-[4-(4-Methyl-piperazin-1-yl)-phenylaMino]-8H-pyrido[2,3-d]pyriMidin-7-one

6-(2-Chloro-4-thiazol-5-yl-phenyl)-8-ethyl-2-[4-(4-Methyl-piperazin-1-yl)-phenylaMino]-8H-pyrido[2,3-d]pyriMidin-7-one

6-(2-Chloro-4-thiazol-5-yl-phenyl)-8-ethyl-2-[4-(4-Methyl-piperazin-1-yl)-phenylaMino]-8H-pyrido[2,3-d]pyriMidin-7-one structure

6-(2-Chloro-4-thiazol-5-yl-phenyl)-8-ethyl-2-[4-(4-Methyl-piperazin-1-yl)-phenylaMino]-8H-pyrido[2,3-d]pyriMidin-7-one 

structure
  • CAS No:

    1286739-19-2

  • Formula:

    C29H28ClN7OS

  • Chemical Name:

    6-(2-Chloro-4-thiazol-5-yl-phenyl)-8-ethyl-2-[4-(4-Methyl-piperazin-1-yl)-phenylaMino]-8H-pyrido[2,3-d]pyriMidin-7-one

  • Synonyms:

    6-(2-Chloro-4-thiazol-5-yl-phenyl)-8-ethyl-2-[4-(4-Methyl-piperazin-1-yl)-phenylaMino]-8H-pyrido[2,3-d]pyriMidin-7-one;FRAX597;Pyrido[2,3-d]pyriMidin-7(8H)-one, 6-[2-chloro-4-(5-thiazolyl)phenyl]-8-ethyl-2-[[4-(4-Methyl-1-piperazinyl)phenyl]aMino]-;6-(2-chloro-4-(thiazol-5-yl)phenyl)-8-ethyl-2-(4-(4-methylpiperazin-1-yl)phenylamino)pyrido[2,3-d]pyrimidin-7(8H)-one;FRAX597, >=98%;6-[2-Chloro-4-(5-thiazolyl)phenyl]-8-ethyl-2-[[4-(4-methyl-1-piperazinyl)phenyl]amino]pyrido[2,3-d]pyrimidin-7(8H)-one

  • Categories:

    Biochemical Engineering  >  Inhibitors

6-(2-Chloro-4-thiazol-5-yl-phenyl)-8-ethyl-2-[4-(4-Methyl-piperazin-1-yl)-phenylaMino]-8H-pyrido[2,3-d]pyriMidin-7-one Basic Attributes

558.09692

557.176

-0

Characteristics

106

5.3

Drug Information

FRAX597

6-(2-Chloro-4-thiazol-5-yl-phenyl)-8-ethyl-2-[4-(4-Methyl-piperazin-1-yl)-phenylaMino]-8H-pyrido[2,3-d]pyriMidin-7-one Use and Manufacturing

General procedure: 6-(4-Bromo-2-chlorophenyl)-8-ethyl-2-(4-(4-methylpiperazin- 1 - yl)phenylamino)pyrido[2, 3-d]pyrimidin-7(8H)-one (12, 194 mg, 0.35 mmol), 5-methyl-2- (tributylstannyl)-thiazole (171 mg, 0.44 mmol), Pd(PPh3)4 (50 mg) and toluene (15 mL) were placed in a microwave tube and flushed with argon. The reaction was heated by microwave at 140 C for 1.5 h. The reaction mixture was evaporated and the solid was extracted with chloroform (100 mL). The solids were removed and the filtrate was evaporated and purified by silica gel chromatography (CHCb/5% MeOH) to afford the compound 46 (17mg, 8%) as yellow solid. LCMS m/z 572 (M+H)+; Rt 1.74min; ' NMR (400 MHz, CDC13) delta ppm 8.56 (s, 1H), 8.04 (s, 1 H), 7.81 - 7.83 (d, 1 H), 7.54 - 7.61 (m, 4H), 7.46 - 7.48 (d, 1 H), 7.32 - 7.37 (s, 1 H), 6.97-7.00 (d, 2H), 4.48-4.54 (q, 2H), 3.24 - 3.26 (m, 4H), 2.63 - 2.65 (m, 4H), 2.54 (s, 3H), 2.40 (s, 3H), 1.38 - 1.42 (t, 3H).

Computed Properties

Molecular Weight:558.1
XLogP3:5.3
Hydrogen Bond Donor Count:1
Hydrogen Bond Acceptor Count:8
Rotatable Bond Count:6
Exact Mass:557.1764574
Monoisotopic Mass:557.1764574
Topological Polar Surface Area:106
Heavy Atom Count:39
Complexity:878
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.